Talking to Lorena Kuri

Episode 139 | 15 JUNE 2021

Talking to Lorena Kuri

This week, we speak to Lorena Kuri, Director of Clinical Trial Diversity Strategy, Bristol-Myers-Squibb, who discusses how to address underrepresentation in clinical trials, how teams can prioritise belonging, and how her experience as a board member of WOCIP has shaped her perspective and ambitions.

Spotify | Apple | Acast

Download MP3 (mp3, 17:57 mins)